CELG, NVS get approvable letter

Celgene (CELG) and partner Novartis (NVS; SWX:NOVN) received an approvable letter from the FDA for dexmethylphenidate (d-MPH), a chiral d-enantiomer of NVS's Ritalin, to treat attention deficit hypera...